Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 067166/0600 | |
| Pages: | 8 |
| | Recorded: | 04/03/2024 | | |
| Attorney Dkt #: | JBI6064USCNT1-103693.2281 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18300183
|
Filing Dt:
|
04/13/2023
|
|
Publication #:
|
|
Pub Dt:
|
09/07/2023
| | | | |
|
Title:
|
Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
|
|
|
Assignee
|
|
|
|
|
| 920 US ROUTE 202 |
| P.O. BOX 300 |
| RARITAN, NEW JERSEY 08869 |
|
|
Correspondence name and address
|
| |
BAKER & HOSTETLER LLP
|
| |
1735 MARKET STREET
|
| |
SUITE 3300
|
| |
PHILADELPHIA, PA 19103-7501
|
Search Results as of:
06/06/2024 03:35 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
